Integrin, beta 2 (complement component 3 receptor 3 and 4 subunit)
|
|
PDB rendering based on 1l3y.
|
Available structures: 1l3y, 1yuk
|
Identifiers
|
Symbol(s)
| ITGB2; LAD; LFA-1; MAC-1; CD18; LCAMB; MF17; MFI7
|
External IDs
| OMIM: 600065 MGI: 96611 Homologene: 20092
|
Gene Ontology
|
Molecular Function:
| • receptor activity • protein binding • protein kinase binding
|
Cellular Component:
| • integrin complex • membrane • integral to membrane
|
Biological Process:
| • apoptosis • inflammatory response • cell adhesion • leukocyte adhesion • cell-matrix adhesion • integrin-mediated signaling pathway • cell-cell signaling • multicellular organismal development • regulation of cell shape • antimicrobial humoral response • neutrophil chemotaxis • regulation of peptidyl-tyrosine phosphorylation
|
|
RNA expression pattern
|
Additional recommended knowledge
More reference expression data
|
Orthologs
|
| Human
| Mouse
|
Entrez
| 3689
| 16414
|
Ensembl
| ENSG00000160255
| ENSMUSG00000000290
|
Uniprot
| P05107
| Q542I8
|
Refseq
| NM_000211 (mRNA) NP_000202 (protein)
| NM_008404 (mRNA) NP_032430 (protein)
|
Location
| Chr 21: 45.13 - 45.17 Mb
| Chr 10: 76.99 - 77.01 Mb
|
Pubmed search
| [1]
| [2]
|
Integrin, beta 2 (complement component 3 receptor 3 and 4 subunit), also known as CD18 or ITGB2, is a human gene.
CD18 is the beta subunit of three different structures:
- LFA-1 (paired with CD11a)
- Macrophage-1 antigen (paired with CD11b)
- Integrin alphaXbeta2 (paired with CD11c)
The ITGB2 protein product is the integrin beta chain beta 2. Integrins are integral cell-surface proteins composed of an alpha chain and a beta chain. A given chain may combine with multiple partners resulting in different integrins. For example, beta 2 combines with the alpha L chain to form the integrin LFA-1, and combines with the alpha M chain to form the integrin Mac-1. Integrins are known to participate in cell adhesion as well as cell-surface mediated signalling.[1]
References
- ^ Entrez Gene: ITGB2 integrin, beta 2 (complement component 3 receptor 3 and 4 subunit).
Further reading
- Bunting M, Harris ES, McIntyre TM, et al. (2002). "Leukocyte adhesion deficiency syndromes: adhesion and tethering defects involving beta 2 integrins and selectin ligands.". Curr. Opin. Hematol. 9 (1): 30-5. PMID 11753075.
- Roos D, Law SK (2003). "Hematologically important mutations: leukocyte adhesion deficiency.". Blood Cells Mol. Dis. 27 (6): 1000-4. doi:10.1006/bcmd.2001.0473. PMID 11831866.
- Gahmberg CG, Fagerholm S (2003). "Activation of leukocyte beta2-integrins.". Vox Sang. 83 Suppl 1: 355-8. PMID 12617168.
- Schymeinsky J, Mócsai A, Walzog B (2007). "Neutrophil activation via beta2 integrins (CD11/CD18): molecular mechanisms and clinical implications.". Thromb. Haemost. 98 (2): 262-73. PMID 17721605.
See also
Proteins: complement system (C, L, A) |
---|
Activators | CLA: C3-convertase - MAC (C6, C7, C8, C9) - L: Mannan-binding lectin - A: Factor P/Properdin |
---|
Enzymes | C: C1Q/C1R/C1S - C4 (A) - C2 - CLA: C3 - C5 (C5a) - L: MASP1 - MASP2 - A: Factor B - Factor D |
---|
Inhibitors | CLA: C1-inhibitor - Decay accelerating factor - Factor I - CL: C4BP - A: Factor H |
---|
Complement receptors | CR1 - CR2 - CR3 - CR4 - CD11b/CD11c/CD18 - Anaphylatoxin (C3a, C5a) |
---|
|